Off-label use of recombinant factor VIIA concentrates after cardiac surgery

Ann Thorac Surg. 2005 Jul;80(1):3-5. doi: 10.1016/j.athoracsur.2005.04.007.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cardiac Surgical Procedures / adverse effects*
  • Factor VII / adverse effects
  • Factor VII / therapeutic use*
  • Factor VIIa
  • Hemostatics / adverse effects
  • Hemostatics / therapeutic use*
  • Humans
  • Postoperative Hemorrhage / drug therapy*
  • Postoperative Hemorrhage / etiology
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use
  • Thromboembolism / etiology

Substances

  • Hemostatics
  • Recombinant Proteins
  • Factor VII
  • recombinant FVIIa
  • Factor VIIa